On Demand: Scaling Home-Based Decongestion in Heart Failure With FUROSCIX® (Furosemide Injection)-Webinar Recording

Video Transcription

Video Summary

The webinar focused on Cone Health’s implementation of a home-based decongestion pathway for heart failure using subcutaneous furosemide (Furosix/ReadyFlow). Moderated by Nicole Dulles, the discussion featured Dr. Ben Simone and Amy Plagg, who explained why their team needed an alternative to hospital-based IV diuresis: many patients worsen gradually, respond poorly to oral diuretics, and are often discharged or sent home still congested.<br /><br />They described where the pathway began—first in the heart failure clinic, then expanded to transitions of care and the emergency department. Key elements of success included objective congestion assessment, clear ownership across providers, nurses, pharmacists, and navigators, and workflows built directly into Epic. The team emphasized that symptoms and weight changes are too late and too subjective, so device-based or other objective measures are important.<br /><br />They also discussed patient education, pharmacy access, prior authorization, and making the process “easy” for staff and patients. Metrics include readmissions, length of stay, and system-wide impact. ReadyFlow was presented as an even simpler, faster option that may support more rapid outpatient treatment and hospital-at-home models.

Keywords

heart failure

home-based decongestion

subcutaneous furosemide

Furosix

ReadyFlow

hospital-based IV diuresis

objective congestion assessment

Epic workflows

readmissions